Margaret H Grinnell, MD - Medicare Family Medicine in Anchorage, AK

Margaret H Grinnell, MD is a medicare enrolled "Family Medicine" physician in Anchorage, Alaska. Her current practice location is 4320 Diplomacy Dr, Anchorage, Alaska. You can reach out to her office (for appointments etc.) via phone at (907) 729-8901.

Margaret H Grinnell is licensed to practice in Alaska (license number 146390) and she also participates in the medicare program. She does not accept medicare assignments directly but she may accept medicare through third-party (refer to Reassignment section below) and may also prescribe medicare part D drugs. Her NPI Number is 1568025567.

Contact Information

Margaret H Grinnell, MD
4320 Diplomacy Dr,
Anchorage, AK 99508-5925
(907) 729-8901
(907) 729-8607



Physician's Profile

Full NameMargaret H Grinnell
GenderFemale
SpecialityFamily Medicine
Location4320 Diplomacy Dr, Anchorage, Alaska
Accepts Medicare AssignmentsMedicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs.
  NPI Data:
  • NPI Number: 1568025567
  • Provider Enumeration Date: 04/16/2019
  • Last Update Date: 09/28/2022
  Medicare PECOS Information:
  • PECOS PAC ID: 9638405061
  • Enrollment ID: I20221007002469

Medical Identifiers

Medical identifiers for Margaret H Grinnell such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1568025567NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207Q00000XFamily Medicine 146390 (Alaska)Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Margaret H Grinnell allows following entities to bill medicare on her behalf.
Entity NameAlaska Native Tribal Health Consortium
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1437189339
PECOS PAC ID: 6709780265
Enrollment ID: O20031125000772

News Archive

Crizotinib drug effectively halts growth of ROS1-positive lung tumors

Treatment with the targeted therapy drug crizotinib effectively halts the growth of lung tumors driven by rearrangements of the ROS1 gene. In an article receiving Online First publication in the New England Journal of Medicine to coincide with a presentation at the European Society for Medical Oncology meeting, an international research team reports that crizotinib treatment led to significant tumor shrinkage in 36 of 50 study participants and suppressed tumor growth in another 9.

GSK updates long-term survival data of BEXXAR Therapeutic Regimen for Non-Hodgkin's lymphoma

GlaxoSmithKline announced today updated long-term survival data from two Phase II studies of BEXXAR® (tositumomab and iodine I-131 tositumomab) used in either patients with previously untreated cancer of the immune system (follicular lymphoma) or in patients with cancer of the lymphocytes (non-Hodgkin's lymphoma, NHL) that no longer responded to rituximab.

FDA approves Chelsea Therapeutics' Phase II protocol for CH-4051 antifolate in rheumatoid arthritis

Chelsea Therapeutics International, Ltd. announced confirmation by the U.S. Food and Drug Administration (FDA) that its proposed Phase II protocol for CH-4051 in rheumatoid arthritis has been approved by the agency.

Farsighted preschoolers, kindergartners have hard time paying attention, study suggests

Farsighted preschoolers and kindergartners have a harder time paying attention and that could put them at risk of slipping behind in school, a new study suggests.

Read more Medical News

› Verified 3 days ago

Entity NameSouthcentral Foundation
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1780614263
PECOS PAC ID: 5496663627
Enrollment ID: O20051027000416

News Archive

Crizotinib drug effectively halts growth of ROS1-positive lung tumors

Treatment with the targeted therapy drug crizotinib effectively halts the growth of lung tumors driven by rearrangements of the ROS1 gene. In an article receiving Online First publication in the New England Journal of Medicine to coincide with a presentation at the European Society for Medical Oncology meeting, an international research team reports that crizotinib treatment led to significant tumor shrinkage in 36 of 50 study participants and suppressed tumor growth in another 9.

GSK updates long-term survival data of BEXXAR Therapeutic Regimen for Non-Hodgkin's lymphoma

GlaxoSmithKline announced today updated long-term survival data from two Phase II studies of BEXXAR® (tositumomab and iodine I-131 tositumomab) used in either patients with previously untreated cancer of the immune system (follicular lymphoma) or in patients with cancer of the lymphocytes (non-Hodgkin's lymphoma, NHL) that no longer responded to rituximab.

FDA approves Chelsea Therapeutics' Phase II protocol for CH-4051 antifolate in rheumatoid arthritis

Chelsea Therapeutics International, Ltd. announced confirmation by the U.S. Food and Drug Administration (FDA) that its proposed Phase II protocol for CH-4051 in rheumatoid arthritis has been approved by the agency.

Farsighted preschoolers, kindergartners have hard time paying attention, study suggests

Farsighted preschoolers and kindergartners have a harder time paying attention and that could put them at risk of slipping behind in school, a new study suggests.

Read more Medical News

› Verified 3 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Margaret H Grinnell is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Margaret H Grinnell, MD
7033 E Tudor Rd,
Anchorage, AK 99507-1262

Ph: (907) 729-8901
Margaret H Grinnell, MD
4320 Diplomacy Dr,
Anchorage, AK 99508-5925

Ph: (907) 729-8901

News Archive

Crizotinib drug effectively halts growth of ROS1-positive lung tumors

Treatment with the targeted therapy drug crizotinib effectively halts the growth of lung tumors driven by rearrangements of the ROS1 gene. In an article receiving Online First publication in the New England Journal of Medicine to coincide with a presentation at the European Society for Medical Oncology meeting, an international research team reports that crizotinib treatment led to significant tumor shrinkage in 36 of 50 study participants and suppressed tumor growth in another 9.

GSK updates long-term survival data of BEXXAR Therapeutic Regimen for Non-Hodgkin's lymphoma

GlaxoSmithKline announced today updated long-term survival data from two Phase II studies of BEXXAR® (tositumomab and iodine I-131 tositumomab) used in either patients with previously untreated cancer of the immune system (follicular lymphoma) or in patients with cancer of the lymphocytes (non-Hodgkin's lymphoma, NHL) that no longer responded to rituximab.

FDA approves Chelsea Therapeutics' Phase II protocol for CH-4051 antifolate in rheumatoid arthritis

Chelsea Therapeutics International, Ltd. announced confirmation by the U.S. Food and Drug Administration (FDA) that its proposed Phase II protocol for CH-4051 in rheumatoid arthritis has been approved by the agency.

Farsighted preschoolers, kindergartners have hard time paying attention, study suggests

Farsighted preschoolers and kindergartners have a harder time paying attention and that could put them at risk of slipping behind in school, a new study suggests.

Read more News

› Verified 3 days ago


Family Medicine Doctors in Anchorage, AK

Candace L Clawson, MD
Family Medicine
Medicare: Not Enrolled in Medicare
Practice Location: 4315 Diplomacy Dr, Anchorage, AK 99508
Phone: 907-729-1624    Fax: 907-729-1634
Dr. William Murray Buttner, MD
Family Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 1201 E 36th Ave, Anchorage, AK 99508
Phone: 907-562-9229    Fax: 907-561-4806
Robert L Mcalister, MD
Family Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 1201 E 36th Ave, Anchorage, AK 99508
Phone: 907-562-2992    
Shane W Cummings, M D
Family Medicine
Medicare: Not Enrolled in Medicare
Practice Location: 1310 E Dimond Blvd, Suite 1, Anchorage, AK 99515
Phone: 907-344-2400    Fax: 907-344-2404
Jeremy D Wood, MD
Family Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 910 Compassion Cir, Anchorage, AK 99504
Phone: 907-212-9200    Fax: 907-212-9283
Kelton Hillard Oliver, MD
Family Medicine
Medicare: Not Enrolled in Medicare
Practice Location: 12302 Woodward Dr, Anchorage, AK 99516
Phone: 907-580-0002    
Ryan T. Mcwilliams, MD
Family Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 4320 Diplomacy Dr, Suite 1191, Anchorage, AK 99508
Phone: 907-729-6321    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.